Direct versus indirect revascularization in the treatment of moyamoya disease by 김동석 et al.
CLINICAL ARTICLE
J Neurosurg 129:480–489, 2018
MoyaMoya disease (MMD), an idiopathic disease first reported by Suzuki and Takaku in 1969,21 results from a progressive occlusion and stenosis 
of the internal carotid artery (ICA). Occlusion typically 
occurs bilaterally and is accompanied by the development 
of abnormal net-like vessels called moyamoya vessels. 
The disease seems to be prevalent in the Asian popula-
tion, where it is common in pediatric patients in the 1st 
decade of life and in 30- to 40-year-old adults. Indirect 
encephaloduroarteriosynangiosis has been a widely estab-
lished treatment strategy for children with MMD because 
of its excellent postoperative results, leading to extensive 
collateral formation and minimal complications.6,15,16 In 
adults, however, the most efficient treatment strategy for 
ischemic patients is a matter of debate. Direct bypass sur-
gery has gained popularity because it provides an immedi-
ate increase in perfusion.7,8,17,23 However, more studies are 
highlighting the effectiveness of indirect surgery.20 Fur-
thermore, authors of many reports are now suggesting that 
a combination of direct and indirect methods is beneficial 
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OBJECTIVE For patients with moyamoya disease (MMD), surgical intervention is usually required because of progres-
sive occlusion of the internal carotid artery. The indirect bypass method has been widely accepted as the treatment of 
choice in pediatric patients. However, in adult patients with MMD, the most effective treatment method remains a matter 
of debate. Here, the authors compared the clinical outcomes from MMD patients treated with either extracranial-intracra-
nial arterial bypass (EIAB; 43 hemispheres) or modified encephaloduroarteriosynangiosis (mEDAS; 75 hemispheres) to 
investigate whether mEDAS is an effective surgical method for treating adults with symptomatic MMD.
METHODS A comparative analysis was performed in patients treated using either mEDAS or EIAB. Collateral grading, 
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RESULTS Seventy-seven percent (58/75) of mEDAS cases and 83.7% (36/43) of EIAB cases in the analysis experi-
enced improvement in their symptoms after surgery. Furthermore, patients in 98.7% (74/75) of mEDAS cases and those 
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both procedures.
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for patients, as this can establish immediate blood flow 
from direct surgery and can lead to a prolonged increase 
in perfusion via an indirect effect.1,3,11,22
Initially, because of the popularity of direct bypass 
surgery, surgeons at our institution mainly performed ex-
tracranial-intracranial arterial bypass (EIAB) for treating 
adults with MMD. However, on long-term follow-up digi-
tal subtraction angiography (DSA), instead of improve-
ment in local perfusion resulting from direct bypass, an 
indirect effect of formation of new vessels in the hypo-
perfused regions of the brain seemed to be prevalent (Fig. 
1). Considering that EIAB is a much more complicated 
surgery and has been reported to carry a relatively high 
risk of postoperative hyperperfusion that can lead to ir-
reversible neurological damage,5,12 surgeons at our insti-
tution began performing indirect modified encephalodu-
roarteriosynangiosis (mEDAS) surgery. Since there was 
no consensual agreement on which surgical method was 
superior in the treatment of adult MMD at the time,2,20 a 
comparative analysis assessing the efficacy of the surger-
ies seemed necessary. In this study, we present and discuss 
the clinical outcomes of symptomatic adult MMD patients 
who underwent either mEDAS or EIAB surgery at our in-
stitution, to determine whether mEDAS is a sufficient and 
safe method for treating adult MMD patients.
Methods
Patient Selection
With the idea that mEDAS surgery on its own may be 
more beneficial than EIAB for the treatment of adult MMD 
patients, we compared patients (age ≥ 20 years at the time 
of surgery) who were treated for MMD with either indirect 
bypass mEDAS (between January 2005 and December 
2014) or direct EIAB surgery (between October 2011 and 
May 2015). Between 2005 and 2011, both direct and indi-
rect bypass surgeries were performed. Direct bypass sur-
geries were favored more often, but in cases in which direct 
bypass was not feasible (for example, when there were no 
suitable vessels for the bypass graft) indirect mEDAS was 
performed. However, when the outcomes of the 2 surger-
ies were primarily followed up, no significant differences 
were seen, which led to the simpler mEDAS recently being 
more favored. All patients underwent surgical treatment at 
Severance Hospital in Korea. Patients undergoing direct 
surgery (EIAB) were treated mainly by vascular surgeons, 
and those undergoing indirect surgery (mEDAS) were 
treated mainly by pediatric neurosurgeons. Unfortunately, 
EIAB data prior to 2011 are rather scarce, and the available 
data are not suitable for a comparative study due to limited 
materials for analysis. However, as there were detailed data 
for mEDAS patients between 2005 and 2014, EIAB data 
from a similar period (2011 and 2015) were used so that a 
meaningful comparison could be made.
All patients presented with ischemic symptoms includ-
ing impairment in motor, sensory, cognition, and/or vision. 
Symptomatic hemispheres were considered for the proce-
dure if they displayed decreased perfusion and/or a lack 
of vascularity when analyzed on 6-vessel DSA, MRI, and/
or Diamox SPECT. In most patients, the surgical side of 
the brain hemisphere was in Suzuki Stage II–IV.21 Some 
asymptomatic hemispheres were treated for preventative 
purposes if they displayed a lack of vascularity (relatively 
defected capillary filling at angiography or severely de-
layed time to peak) or if patients complained of severe 
headache or dizziness (as these are non–hemisphere-spe-
cific symptoms, it was deemed asymptomatic) even in the 
absence of transient ischemic attack (TIA) or infarct. This 
study was approved by the institutional review board.
Surgical Technique
Modified EDAS
Modified EDAS was performed using a split dura ma-
ter as previously described,10 with some modifications. Af-
ter exposure of the superficial temporal artery (STA), the 
galea was cut parallel to the STA at a distance of 5 mm, 
so that a strip of galea was attached to the artery over its 
entire exposed length. The galeal flap was made as long as 
possible. Then, the temporalis muscle and the pericranium 
were incised linearly and denuded from the skull. A wider 
craniotomy than that done for standard EDAS was per-
formed (average diameter 66 mm). The linear single dural 
incision on the outer layer of the dura was made parallel to 
the galeal flap and the meningeal arteries. The meningeal 
dura was stripped from the periosteal dura. The meningeal 
dura was then removed to allow direct contact between the 
middle meningeal artery and the cerebral cortex. Finally, 
the remaining periosteal dura was sutured with the galeal 
flap. Bleeding from the dural incision or separation was 
controlled using Surgicel (Ethicon) and gentle compres-
sion, with minimal use of bipolar coagulation. The elevat-
ed bone flap was repositioned to its original site with ab-
sorbable material. This procedure developed from the idea 
of obtaining donor vessels from the dural arterial supply 
as well as the posterior branch of the STA, thereby being 
able to insert 2 vessels during a single surgery. The intra-
operative PaCO2 levels were strictly controlled between 
35 and 45 mm Hg, and the mean arterial blood pressure 
was maintained between 100 and 120 mm Hg. To control 
postoperative pain from the surgical wounds, an intermit-
tent injection of fentanyl or a continuous drip of morphine 
(0.1 mg/kg in 1 L of normal saline and 0.035 mg/min/kg, 
respectively) was used. Postoperative complications were 
minimized as previously described.13
EIAB
A conventional STA–middle cerebral artery (MCA) 
anastomosis was carried out.19 In brief, the patient was 
placed supine, and an incision was made directly over the 
STA branch. The exposed STA was isolated and was mo-
bilized from the galeal layer over the temporalis muscle 
to prepare for anastomosis. The temporalis muscle was 
divided and dissected from the underlying bone and then 
retracted laterally. The dura was opened, and a suitable 
recipient MCA branch was identified and dissected from 
the artery.
Temporary clips were placed across the MCA recipi-
ent branch to interrupt blood flow. The donor STA was 
divided at an angle and spatulated for anastomosis. End 
stitches were placed at the heel and the end of the spatulat-
ed artery. An interrupted or running suture array was then 
placed at the edge of the arteriotomy. After completion of 
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the arteriotomy, temporary clamps were removed for flow 
establishment. Leakage was mitigated with Surgicel.
Postoperative Follow-Up
Clinical Symptoms
Follow-up of clinical symptoms, based on patient re-
porting, was done at the outpatient clinic. As all patients 
had ischemic MMD, mostly motor symptoms were report-
ed with no significant cognitive decline.
Postoperative MMD MRI Protocol
The routine postoperative follow-up was performed us-
ing an MRI protocol that was specially designed at our 
institution. The development of collateral vasculature and 
the progression of MMD were examined using magnetic 
resonance angiography (MRA). Three-dimensional time-
of-flight MRA (TR 8.6 msec, TE 12 msec, 7° flip angle) 
was performed using a 3.0-T system (InteraAchieva, 
Philips Medical Systems) with an 8-channel sensitivity-
encoded head coil. The orientation of the volume slab 
was chosen to cover the circle of Willis, posterior cere-
bral artery, and MCA. The slab was 64 mm thick with 64 
partitions, resulting in a section thickness of 1 mm. The 
acquisition matrix was 512 × 512, and the FOV measured 
23 cm. Echo planar imaging was performed during an in-
travenous bolus injection of 0.2 mmol/kg of gadopentetate 
dimeglumine (Magnevist, Schering AG) with the follow-
ing parameters: TR 8.6 msec, TE 12 msec, number of ac-
quisitions 1, flip angle 7°, echo planar imaging factor 7, 
section thickness 3.5 mm without a gap, a FOV 23 cm, and 
an acquisition matrix of 128 × 128.
Image Analysis
Collateral Grade
Preoperative and postoperative MRA results were eval-
uated by a medical team (2 radiologists and 2 neurosur-
geons) who made diagnoses by consensus. Postoperative 
MR angiograms were compared with preoperative studies 
to evaluate the transdural collateral vessels and monitor 
changes in STA and moyamoya vessels.
Collateral Grades 1, 2, and 3 were determined from 
DS angiograms and/or MR images according to the extent 
of formation of transdural involvement in the MCA ter-
ritory at the synangiosis site (adapted from conventional 
angiography criteria) according to the grading system of 
Nakashima et al. (Fig. 2).18
FIG. 1. Indirect effect after direct bypass surgery. This patient underwent EIAB surgery in March 2012. A: Preoperative DS angio-
gram (lateral view, upper) and image showing the craniotomy site (lower). B: Postoperative DS angiograms (lateral view) obtained 
in March 2012. Immediate improvement in circulation from the direct bypass is shown within the black circles. C: Follow-up DS 
angiograms (lateral view) obtained in August 2014. An indirect effect (white circle), occurring adjacent to the direct bypass site, 
seems to be prevalent.
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Collateral Vein Count
For a more quantitative analysis of the extent of col-
lateral formation, using a DS angiogram or 3D-TOF-MR 
angiogram we counted the number of cortical veins in the 
ICA system into which the external carotid artery system 
drains on a DS angiogram or 3D-TOF-MR angiogram 
(Fig. 3). After craniotomy, collaterals form in the crani-
otomy site and ischemic regions beyond the craniotomy 
site. These collaterals drain into several drainage veins in 
the ICA circulation. The number of drainage veins, there-
fore, is representative of the extent of collateral formation.
Results
Patient Demographics
Modified EDAS surgery was performed in 74 hemi-
spheres in 57 adult MMD patients at our institution (Table 
1). Two additional patients who had undergone unilat-
eral EDAS at another hospital underwent contralateral 
mEDAS surgery at our institution. In these patients, the 
outcomes of the surgically treated hemispheres at another 
hospital were included in our data analysis. However, 1 
patient who underwent unilateral surgery was lost to fol-
low-up. Therefore, data from 75 surgeries were used in our 
data analysis.
EIAB was performed in 44 hemispheres in 41 adult 
MMD patients. However, 1 patient was excluded from the 
outcome data analysis because follow-up was done at an-
other hospital. Therefore, clinical outcome data from 43 
hemispheres were included in our study.
The mean patient age at the time of surgery was 28.7 
years for mEDAS and 36.0 years for EIAB. The medi-
an follow-up durations for mEDAS and EIAB were 42 
months (range 6–132 months) and 22 months (range 1–45 
months), respectively. Most patients presented with motor 
symptoms prior to surgery, and a few patients presented 
with sensory, cognitive, and visual symptoms. Most sur-
geries were carried out in hemispheres at Suzuki Stages 
II–IV.
Measurement of Operative Time
Operative times were recorded by the anesthetist in the 
operating room where the initiation and termination of the 
surgery was clarified by the main surgeon. The mean op-
erative time for EIAB surgery was 397 minutes (250–565 
minutes), whereas for mEDAS surgery it was 109 minutes 
(91–225 minutes).
Length of Postsurgical Stay in the Hospital and the ICU
Hospital and intensive care unit (ICU) lengths of stay 
(LOSs) were recorded as indicated in the patient chart. 
mEDAS patients had an average hospital LOS of 5 days, 
and no ICU stay after the surgery. EIAB patients had an 
average hospital LOS of 20 days, and an ICU stay for at 
least 1 week after the surgery.
Clinical Symptom Improvement
Follow-up of clinical symptoms was performed in the 
outpatient clinic. Of the 75 mEDAS surgeries, patients in 
51 cases (68%) exhibited no significant symptoms, and 
patients in 7 cases (9.3%) presented with decreased fre-
quency of TIAs after surgery. In total, patients in 77.3% 
of cases exhibited symptom improvement. Unfortunately, 
patients in 6 cases (8%) had an increased frequency of 
TIAs in the immediate postoperative period, and those in 
FIG. 2. Collateral grade determination based on DSA (upper [in each panel, anteroposterior and lateral views appear on the left 
and right, respectively]) and MRA (lower). Regions of interest are marked with white circles on the MRA scans. A: Grade 1. 
Thickening of STA is seen on both DSA and MRA. B: Grade 2. Focal collateral seen on DSA, where there is initiation of cortical 
collateral development. On MRA, collaterals are displayed as spots (“spot sign”) C: Grade 3. Broad collateral seen on the DS 
angiogram, where there is network formation between collateral circulation parenchymal vessels. On MRA, the collaterals are 
connected and appear as a weblike network.
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11 cases (14.7%) suffered cerebral infarction. Of these 11 
cases, patients in 7 cases suffered infarction in the preop-
erative period. This indicates that 63.6% (7 of 11) of the 
cases in which patients with infarct complication in the 
postoperative period are those with a higher risk of infarc-
tion from the natural progression of the disease.
Of the 43 EIAB surgeries, patients in 27 cases (62.8%) 
exhibited no symptoms, and those in 9 cases (20.9%) ex-
perienced decreased TIA frequency. In total, patients in 
83.7% of the cases exhibited improved symptoms. Howev-
er, patients in 5 cases (11.6%) had an increased frequency 
of TIAs and those in 2 cases (4.7%) experienced cerebral 
infarction . In addition, there were 2 cases of wound dehis-
cence. These were treated immediately and did not lead to 
long-term complications.
Collateral Grade
In addition to symptom analysis, the collateral grades 
in patients were determined according to the extent of col-
lateral vessel formation after surgery. Here, we considered 
a collateral grade of 1 or more a positive outcome because 
patients with Grade 1 collaterals exhibited some level of 
collateral formation, and the collateral grade progres-
sively improved with time (p < 0.01) for both EIAB and 
mEDAS surgeries (Fig. 4). On this basis, we can conclude 
that 98.7% of mEDAS surgeries led to favorable collateral 
grades. The collateral vessels were Grades 0, 1, 2, and 3 
in 1, 19, 27, and 28 cases, respectively. For EIAB cases, 
95.3% had favorable collateral grades; the collaterals were 
Grades 0, 1, 2, and 3 in 2, 5, 24, and 12 cases at Grade 3, 
respectively.
Collateral Drainage Vein
Although the collateral grade is a good way of measur-
ing the outcomes after surgery, we devised a new method 
of grading that is more quantitative and objective. To de-
termine the extent of territories populated by collateral 
vessels, we viewed the DS angiogram or 3D-TOF-MR 
angiogram to count the number of cortical veins in the 
ICA circulation into which the regions of collaterals drain. 
Of the hemispheres treated, 20 mEDAS hemispheres and 
35 EIAB hemispheres have undergone postoperative an-
giographic follow-up, and 53-mEDAS and 8-EIAB hemi-
spheres have undergone 3D-TOF-MRA follow-up. Two 
FIG. 3. Cortical veins in the ICA circulation were counted on DS angiograms (lateral views). A: The craniotomy site is shown.  
B: Regions that lack vessels are shown. The ischemic regions are larger than the craniotomy site. C: The collaterals generated 
after mEDAS surgery are seen to populate the ischemic regions shown in panel B. D: Veins counted in the ICA circulation (ar-
rows). These were absent on the preoperative DS angiogram but were present on postoperative DS angiogram.
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mEDAS-treated hemispheres were excluded from vein 
count as the MRA scans were insufficient for vein count-
ing. A larger number of affected veins represent a larger 
area of collateral formation, indicating effectiveness of the 
surgery. As shown in Fig. 5, there is a strong positive cor-
relation (p < 0.01) between collateral grades and number 
of drainage veins, where the number of veins increased as 
grades increased in both groups.
Discussion
Adult patients with symptomatic MMD have a chronic 
decrease in blood flow. It is therefore necessary to estab-
lish good collateral circulation to prevent the risks of is-
chemia and hemorrhage.23 To date, it has not been decided 
whether direct or indirect surgery is best for treating adults 
with symptomatic MMD. Through this study, we hope to 
impart our view that mEDAS is a sufficient surgical meth-
od for adult MMD treatment and that it is more beneficial 
for patients than EIAB.
In this study, for choosing the method of intervention, 
patients and their families decided on the treatment option 
after receiving sufficient information on both mEDAS and 
EIAB procedures. As this was not a process that could be 
randomized, some differences in the patient demographics 
were inevitable. Patient age and Suzuki stages at the time 
of surgery differ slightly between mEDAS and EIAB. For 
mEDAS patients, the age at operation varied between 20 
and 48 years, with 56% of patients being 20–30 years at 
the time of surgery. On the other hand, for EIAB patients, 
the age at operation ranged from 19 to 61 years, and 44% 
of patients were between 30 and 40 years old at the time 
of surgery. Considering Suzuki stages, 16% of EIAB cases 
were higher than Stage III, whereas 31% of mEDAS cases 
were higher than Stage III. Therefore, in general, mEDAS 
patients were younger but had more advanced MMD, and 
EIAB patients were slightly older but had less advanced 
MMD. As mEDAS has proven to be effective in pediatric 
patients, it is expected that the surgery will yield beneficial 
results when performed in younger adults. For advanced-
stage MMD, if the patient is older, EIAB surgery carries 
higher risks as it destroys natural collaterals. Therefore, 
given that the outcome of mEDAS and EIAB surgeries are 
similar, mEDAS could be used not only in younger adult 
patients, but also in older patients with advanced MMD as 
an alternative method to EIAB.
Most studies of adult MMD focus on patients with 
hemorrhagic MMD. At our institution, however, patients 
with hemorrhagic MMD are not candidates for mEDAS. 
Although it has been indicated that direct and/or indirect 
bypass surgery could reduce the risk of recurrent hemor-
rhage in hemorrhagic patients,17 the results are limited.4 
Due to the lack of definitive evidence supporting the posi-
tive effect of bypass surgery on patients with hemorrhagic 
MMD, these patients usually receive supportive manage-
ment, such as catheter insertion for hematoma removal or 
relief of hemorrhagic hydrocephalus.
The mean follow-up periods were 42 months (range 
6–132 months) and 22 months (range 1–45 months) for 
mEDAS and EIAB patients, respectively. The difference 
in the follow-up duration is due to the fact that data from 
EIAB surgeries were more recent than those from mEDAS 
procedures. However, despite the difference, the follow-up 
duration for EIAB was comparable to that in other MMD 
studies (32.7 months in the study by Gazyakan et al.,7 and 
6 months to 2 years in the study by Li et al.14) and, with the 
presence of reports showing that that there are no signifi-
cant changes in clinical outcome 3 years after surgery,17 
we deemed that it was a representative length of follow-up 
for assessing the outcome.
Assessment of Clinical Outcomes and Complications
In recording the clinical presentations of the patients in 
our study, we found that 77.3% of mEDAS surgeries and 
83.7% of EIAB surgeries led to improved clinical symp-
toms of MMD. Although the percentage of patients with 
improved clinical symptoms was higher after EIAB, it was 
relatively clear that mEDAS surgery also led to good out-
comes, which is why the mEDAS surgery was not aban-
doned.
Unfortunately, TIA and infarction incidents occurred 
after mEDAS (8% and 14.7%, respectively) and EIAB 
(11.6% and 4.7%, respectively). Because the patients in 
our study had symptomatic MMD, the presence of TIA 
TABLE 1. Preoperative patient demographics
Variable mEDAS EIAB
Mean age in yrs (range) 28.7 (20–48) 36.0 (19–61)
Sex*
 Female 42 32
 Male 15 9
Bilateral moyamoya surgery*
 Yes 19 2
 No 38 38
Preop symptoms†
 Motor 40 27
 Sensory 3 2
 Cognitive 2 0
 Vision 2 0
 Multiple symptoms
  Motor & sensory 4 6
  Motor & vision 2 3
  Motor, sensory, & cognition 1 0
  Motor, sensory, & vision 0 2
  Nonspecific symptoms‡ 3 1
Preop Suzuki stage†
 I 3 1
 II 15 14
 III 34 22
 IV 20 7
 V§ 2 0
 IV§ 1 0
* Number of patients.
† Number of hemispheres.
‡ Headaches and dizziness.
§ Surgery was performed at late Suzuki stages because of severe symptom 
presentation.
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and infarction may stem from the natural progression of 
the disease, rather than from surgical complication. It has 
been previously indicated that the occurrence of preopera-
tive infarction is associated with a higher risk of postop-
erative complications.9,13 As 63.6% of the postoperative 
infarct patients in the mEDAS group suffered infarction in 
the preoperative period, this factor may contribute to the 
relatively high level of infarction in mEDAS patients. In-
farct patients had unstable blood perfusion and advanced 
disease stage, suggesting that they generally did not have 
suitable vessels for direct bypass surgery. In these cases, 
the simpler mEDAS was preferred over EIAB, which con-
tributes to the skewing of preoperative infarction occur-
ring in patients with advanced stage disease to mEDAS. 
Even so, an additional method for controlling complica-
tions, beyond what is already in place, should be developed 
to further decrease perioperative ischemic complications.
The results of our study show that 98.6% of mEDAS 
cases and 95.3% of EIAB cases had positive postoperative 
collateral grades where we could see postoperative collat-
eral formation. Furthermore, for both EIAB and mEDAS 
cases, the proportion of cases at Grade 2 or 3 were higher 
FIG. 4. Change in collateral grading against length of follow-up for both EIAB and mEDAS patients. Upper: Collateral grades for 
the 43 EIAB surgeries. The number of cases at Grade 3 increased with time, whereas those for Grades 0, 1, and 2 all decreased. 
The effect was not as prevalent, as only 16 patients were underwent follow-up for more than 24 months, whereas 27 patients 
underwent follow-up for less than 24 months. Lower: Collateral grades for the 75 mEDAS surgeries. Cases at Grades 2 and 3 
increased, while cases at Grade 1 decreased with time, indicating that the collateral grade increases with the length of follow-up 
(F/U) (p < 0.01). 
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when the patients underwent follow-up for more than 24 
months rather than less than 24 months (77.8% to 93.8% 
for EIAB patients and 60% to 85% for mEDAS patients). 
This indicates a general trend of collateral grade improve-
ment upon increase in follow-up length. Therefore, even 
if the collateral grade at the time of follow-up is not as 
high as expected, it is likely that it will improve with time. 
Although this effect is seen in both groups, the effect for 
EIAB patients may be due to an indirect effect from crani-
otomy, which facilitates improvement of grade over time. 
This is an important factor to consider when interpreting 
results from direct bypass surgeries, because these results 
not only reflect the direct effect of the surgery, but also 
include the indirect bypass effect generated from crani-
otomy.
In this study, we devised a more quantitative and ob-
jective method of determining the extent of collateral for-
mation, which involves counting the drainage veins in the 
ICA circulation. We found a strong positive correlation 
between collateral grades and collateral drainage veins 
FIG. 5. Graphs showing the number of collateral drainage veins at each collateral grade. Strong positive correlation between 
postoperative collateral grades and the number of collateral drainage veins are seen in both cases (p < 0.01). Upper: For EIAB 
surgeries, there were 2–4 Grade 1 veins, 2–5 Grade 2 veins, and 4–7 Grade 3 veins. Lower: For mEDAS surgeries, there were 3 
Grade 0 veins, 0–4 Grade 1 veins, 3–6 Grade 2 veins, and 3–7 Grade 3 veins.
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in both surgical groups (Fig. 5). As collateral grade was 
shown to improve with time, we also expect the number of 
collateral drainage veins to increase with time. This indi-
cates that there will be a progressive increase in the area 
perfused by collateral vessel formation, which fulfills the 
objective of the surgery and also yields comparable out-
come to EIAB surgery.
The modified Rankin Scale score is commonly used for 
assessing the outcome of patients; however, we did not use 
the modified Rankin Scale, as all patients were at Score 0 
or 1, and no significant data set could be generated.
Patient Experience
The results that we have presented, based on symptom 
analysis, collateral grading, and collateral vein count, sug-
gest that the outcomes generated by mEDAS and EIAB 
surgeries were not significantly different. However, when 
we considered patient experience, a clear difference be-
came obvious. The mean operative time for EIAB surgery 
was 397 minutes, 3.5 times longer than the 109 minutes 
for mEDAS surgery, indicating that EIAB patients went 
through a much more strenuous surgical process. Also, 
the hospital and ICU LOSs were shorter for mEDAS pa-
tients than for for EIAB patients. Patients who underwent 
mEDAS had an average hospital LOS of 5 days and did 
not have to stay in the ICU after surgery. In contrast, EIAB 
patients had a hospital LOS of approximately 20 days, 
and they had to stay in the ICU for at least 1 week after 
surgery. This significant difference in overall ICU and 
hospital LOSs suggests that mEDAS is a simpler surgery 
that does not disrupt the patient’s life as much as EIAB 
surgery. Further supporting our arguments for choosing 
mEDAS are studies showing that some EIAB patients have 
reported complications of hyperperfusion syndrome after 
surgery.5,12 Because MMD patients present with ischemic 
symptoms due to unstable perfusion, hyperperfusion syn-
drome is a serious complication that needs to be taken into 
consideration.
Conclusions
It would be difficult to argue against the efficacy of 
EIAB surgery for the treatment of adults with symptomat-
ic MMD. This method has been proven to establish imme-
diate blood flow in regions with decreased perfusion, and 
multiple reports have presented favorable outcomes stem-
ming from EIAB surgeries. Our goal in this study, howev-
er, was not to dispute the efficiency of EIAB as a treatment 
option, but to consider which surgical intervention provides 
greater benefits for MMD patients. The clinical outcome 
should be considered as one of the most important factors 
for choosing the surgery. However, the risks of surgery and 
the quality of patient experience should also be consid-
ered. Modified EDAS, when compared with EIAB, is a 
surgery that ensures shorter operative times, shorter ICU 
and hospital LOSs, and decreased risks of complication. 
Also, mEDAS has been shown to produce positive clinical 
outcomes, which, over time, will be comparable to those 
from EIAB. In addition, we have shown that mEDAS pa-
tients do not suffer from serious complications, whereas 
EIAB patients run the risk of hyperperfusion. Therefore, 
considering both the clinical outcomes and patient experi-
ence aspect of the 2 treatments, we believe that mEDAS is 
at the least an equivalently effective treatment option for 
adult symptomatic MMD patients as EIAB.
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